✦ LIBER ✦

Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells

✍ Scribed by Jian Huang; Ting Ding; Min Yang; Hui Liu; Xin Sun; Jie Jin

Book ID: 107619266
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 841 KB
Volume: 93
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-011-0821-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

397 POSTER Potentiation of the antitumor

397 POSTER Potentiation of the antitumor activity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines

✍ T. Cascone; F. Morgillo; G. Laus; S. Pepe; F. Ciardiello 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 1 views